• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

News

Article

Interview Intersection: Expert Interviews From December 2024

Dermatology Times is recapping our top expert interviews from the month of December.

December Interview Intersection logo

Navigating Challenges and Inspiring Advocacy: A Pre-Med Student's Journey With HS

Dena Antowan shares her journey balancing pre-med life, managing HS, advocating on TikTok, and her vision for empathetic dermatologic care.

“ARM Yourself with Knowledge": Emmy Graber, MD, MBA, Shares Insights on Acne, Rosacea, and More

Graber spoke with Dermatology Times to share the top clinical pearls and key takeaways from the recent meetings.

Topics and Pearls

  • Disease states such as acne, alopecias, chronic inducible/spontaneous urticaria, hidradenitis suppurativa, and rosacea
  • Pearls for aesthetics
  • Conference data and insights

Exploring EVO756 in Chronic Inflammatory Disease Treatment: Q&A with Evommune's Mark Jackson, MD

Jackson discusses EVO756, a promising MRGPRX2 antagonist targeting mast cells to treat chronic inflammatory diseases like spontaneous urticaria.

Wealth Strategies for Today’s Physician: David Mandell, JD, MBA, Shares Insights from New Playbook

The latest publication from OJM Group provides 7 core strategies for dermatologists looking to meet their financial goals.

Jason Hawkes, MD, MS: Looking Back on 2024, Ahead to 2025

Hawkes shared his excitement for the near future of dermatology, recognizing the increasing ability to provide tailored care to patients.

The Importance and Role of Advocacy in the Approval of ICD-10 Codes for CCCA and FFA

Itisha S. Jefferson, a patient advocate and medical student, discusses the significance of new ICD-10 codes for CCCA and FFA, improving diagnosis and care.

Don’t miss a moment of Dermatology Times by signing up for our eNewsletters and subscribing to receive the free print issue and supplements each month.

Related Videos
infectious disease
© 2024 MJH Life Sciences

All rights reserved.